In the Spotlight

FDA Decision Stresses Need for Qualified Doctor
The U.S. Food and Drug Administration’s (FDA) announced on April 30, 2009 that a warning will be added to the labeling of botulinum toxin products and a medication guide will be distributed to patients receiving these products for any use. In dermatology, these products are FDA-approved for the treatment of frown lines between the eyebrows and severe underarm sweating (hyperhidrosis). Dermatologist David M. Pariser, MD, president of the American Academy of Dermatology stated, “While no serious side effects have been reported from the dermatologic use of botulinum toxin products, the FDA’s actions emphasize the importance of selecting a qualified physician to administer these products for medical and cosmetic uses.”

To see a list of questions that you should ask before receiving a treatment with botulinum toxin, visit this press statement, American Academy of Dermatology Responds to FDA Decision Regarding Botulinum Toxin Products.

Cheaper Isn't Always Better
How to evaluate the deals offered for cosmetic procedures
It seems that just about everyone is cutting back on expenses these days. While this trend offers consumers some great deals, you sometimes need to consider more than price to know how great a deal really is. The following explains two points you should consider before a cosmetic procedure to avoid compromising your safety and results. (more...)

Supported by an educational donation provided by The Allergan Foundation.